Article
Envision Pharma Group
The MANY ways COVID-19 has made Medical Affairs and MSLs BETTER
Summary
In this episode, JR Ryskala and Petrina Pellet join Tom Caravela to explore the evolving landscape of medical affairs amidst a shift to virtual engagement. The discussion covers the benefits and challenges of virtual interactions and examines how MSL roles and skillsets are adapting post-pandemic. The guests offer insights into balancing virtual and in-person activities and share predictions for future MSL operations. They also discuss strategies for maintaining KOL relationships and the broader impacts of the pandemic on personal and professional levels. The episode concludes with reflections on the global reach of MSL Talk and the value of networking opportunities.
Check out my latest podcast with Jihad “JR” Rizkallah, Director, MSLs at Sunovian and Patrina Pellett, VP, Strategic Accounts at MedEvoke, and we discuss the MANY ways COVID-19 has made Medical Affairs and MSLs BETTER.
We discuss:
Some of the major trends in Medical Affairs
What MSL interactions will look like in the future
The positives that have come out of the COVID Pandemic
How MSLs can stay on track and evolve
Other tips for better performance
medical affairs, virtual engagement, MSL roles, KOL relationships, COVID-19 impact
Related Topics
You May Also Like
Envision Pharma Group
Article
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Podcast
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
Podcast
MSL Talk: Tom Caravela, Daniel Snyder
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois